|
Re: eGFR and Cognition?
|
2
|
Resverlogix Corp.
|
Nov 22, 2019 01:49PM
|
|
Re: Resverlogix Announces Conversion of US$12 Million Debenture Strengthening Balance Sheet
|
2
|
Resverlogix Corp.
|
Oct 14, 2020 11:07AM
|
|
Market reaction to SGLT2i and Jardiance?
|
2
|
Resverlogix Corp.
|
Nov 19, 2019 12:58PM
|
|
Ethics Approval?
|
3
|
Resverlogix Corp.
|
Oct 12, 2021 04:49PM
|
|
Re: Message from Sarah this early afternoon regarding the warrants
|
3
|
Resverlogix Corp.
|
Jan 10, 2020 05:05PM
|
|
Re: Someone please post a link to the slides.
|
3
|
Resverlogix Corp.
|
Dec 06, 2019 09:08AM
|
|
Re: Trial delay
|
3
|
Resverlogix Corp.
|
May 04, 2021 05:47PM
|
|
Re: Nice run for Hepa over the holidays
|
3
|
Resverlogix Corp.
|
Jan 06, 2020 11:39PM
|
|
Re: Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
|
3
|
Resverlogix Corp.
|
Jun 09, 2020 09:13PM
|
|
What's the deal with Zenith?
|
3
|
Zenith Epigenetics
|
Jun 21, 2023 04:54PM
|
|
And 10% up again
|
3
|
Resverlogix Corp.
|
Aug 06, 2020 09:49PM
|
|
Re: #Covid19 Interview of Nevan Krogan, PDF of article
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 11:25AM
|
|
Re: Two Interesting Articles - 2 of 2: COVID-19: consider cytokine storm syndromes and immunosuppression
|
3
|
Resverlogix Corp.
|
Apr 15, 2020 09:51AM
|
|
Re: Risk vs Reward moving forward!
|
3
|
Resverlogix Corp.
|
Dec 17, 2021 04:52PM
|
|
EFGR!!!
|
3
|
Resverlogix Corp.
|
Mar 27, 2020 02:13PM
|
|
Re: Resverlogix Announces Publication in High-impact Peer-reviewed Journal – Medicinal Research Reviews
|
3
|
Resverlogix Corp.
|
Sep 15, 2020 09:22AM
|
|
Re: Just get it DONE $$$ DON!!!
|
3
|
Resverlogix Corp.
|
Nov 04, 2021 01:07PM
|
|
Update from IR -- Eversana paused?
|
4
|
Resverlogix Corp.
|
Dec 16, 2022 08:18PM
|
|
Re: Time keeps ticking
|
4
|
Resverlogix Corp.
|
Nov 17, 2021 06:05PM
|
|
Re: SF
|
4
|
Resverlogix Corp.
|
Sep 17, 2020 01:57PM
|
